📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-06 19:03
0 analysed today
0
Today
133,620
All-time analysed
40,132
Positive
6,284
Negative
79,384
Neutral
7,752
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
23 announcements match the current filters (relevance ≥ 5).
TruAlt Bioenergy FY26 PAT Drops 34.6% to ₹96.87 Cr; AGM Scheduled for Aug 31, 2026
TruAlt Bioenergy has issued its FY26 Integrated Annual Report and scheduled its 5th AGM for August 31, 2026. The company reported a 9.45% decline in consolidated revenue to ₹1,727.51 cr and a sharp 34.57% drop in PAT to ₹96.87 cr for FY26. The decline was primarily driven by reduced ethanol lifting by OMCs and higher finance costs (₹160.02 cr) related to new grain-based plant debt. Despite the profit dip, the company successfully capitalized a 1,300 KLPD grain-based plant, increasing its total installed capacity to 2,000 KLPD.
Confidence: HIGH
What changedThe company has formalized its FY26 financial results and scheduled its AGM, confirming a significant year-on-year decline in profitability and revenue.
Why it mattersThe results highlight the company's vulnerability to government-controlled ethanol procurement and OMC lifting schedules, despite significant capacity additions in the grain-based segment.
Consolidated Revenue (FY26): ₹1,727.51 crConsolidated PAT (FY26): ₹96.87 crRevenue Growth (YoY): -9.45%PAT Growth (YoY): -34.57%Finance Cost (Consolidated): ₹160.02 crAGM Date: August 31, 2026
📅 Short termThe stock may experience negative sentiment in the short term as the market reacts to the audited decline in annual profits and revenue.
📈 Long termLong-term prospects depend on the successful scaling of the CBG vertical and SAF entry by FY28, alongside improved capacity utilization of the 1,300 KLPD dual-feed plant.
⚠ Risk flags
- Client concentration (OMCs)
- Regulatory risk regarding ethanol pricing and lifting
- Rising finance costs from debt-funded expansion
Key Highlights
Consolidated Revenue for FY26 decreased 9.45% YoY to ₹1,727.51 cr from ₹1,907.72 cr.
Consolidated Profit After Tax (PAT) fell 34.57% YoY to ₹96.87 cr, with EPS dropping to ₹12.30 from ₹20.94.
Finance costs rose to ₹160.02 cr due to additional working capital and interest on the new grain-based plant.
Installed capacity stands at 2,000 KLPD, with 1,300 KLPD recently converted to dual-feed capability.
Revenue was impacted by a pending 15 crore litre allocation following a Karnataka High Court order.
👀 What to Watch
Investors should monitor the resolution of the Karnataka High Court order regarding the 15 crore litre allocation and the stabilization of ethanol lifting by OMCs. The execution of the 17 planned CBG plants and the FY28 entry into the Sustainable Aviation Fuel (SAF) market are key long-term growth drivers to watch.
TruAlt Q1 FY27 PAT Jumps 1,000% to ₹59.3 Cr; Secures ₹150 Cr SAF Funding
TruAlt Bioenergy reported a robust Q1 FY27 with revenue reaching ₹626.9 crore, a 106.3% QoQ increase, driven by 8.5 crore litres of ethanol sales. Net profit surged to ₹59.3 crore from ₹4.7 crore in the previous quarter, aided by the conversion of plants to dual-feed (multi-grain) capabilities. The company secured ₹150 crore in viability gap funding for its Sustainable Aviation Fuel (SAF) project and is progressing on CBG JVs with Sumitomo and GAIL. Management has guided for higher sales of 11-12 crore litres in Q2 FY27.
Confidence: HIGH
What changedThe company has successfully transitioned to a multi-feed ethanol model and utilized IPO proceeds to stabilize working capital, leading to a massive jump in quarterly profitability.
Why it mattersThe shift to dual-feed plants reduces dependence on sugarcane and allows for higher margins using cheaper grains, while the SAF and CBG verticals provide long-term high-margin diversification.
Q1 FY27 Revenue: ₹626.9 crQ1 FY27 PAT: ₹59.3 crSAF Funding Secured: ₹150 crQ1 Revenue vs FY26 Annual Revenue: 44.03%Ethanol Capacity Utilization: 60%CBG PBT Margin: 45%
📅 Short termThe stock is likely to react positively to the significant QoQ earnings turnaround and the clear growth guidance for Q2 sales volumes.
📈 Long termStructural growth is supported by the entry into the SAF market by FY28 and the rollout of 100 retail outlets, though the latter is currently slowed by geopolitical factors.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Pending court case for 15 crore litre capacity implementation
- Raw material price volatility for maize and rice
- Geopolitical risks delaying retail outlet expansion
Key Highlights
Net Profit (PAT) surged over 1,000% QoQ to ₹59.3 crore from ₹4.7 crore in the preceding quarter.
Secured ₹150 crore viability gap funding from the Government of India for the Sustainable Aviation Fuel (SAF) business.
Ethanol sales volume reached 8.5 crore litres in Q1, with management targeting 11-12 crore litres for Q2 FY27.
CBG segment reported high profitability with a PBT margin of approximately 45% on ₹11.2 crore revenue.
Three out of four CBG plants under the Sumitomo JV are nearing commissioning, expected by Q3 FY27.
👀 What to Watch
Monitor the commissioning timeline of the Sumitomo JV plants in Q3 FY27 and the legal resolution regarding the additional 15 crore litre ethanol capacity which could boost utilization to 95%.
Rs 171 Cr Slump Sale of Non-Core Unit 5 to Reduce Debt and Interest Costs
TruAlt Bioenergy has approved the sale of its non-operational Unit 5 in Karnataka to Onkar Agro Sugars & Energy for Rs 171 crore. The unit contributed zero revenue in FY26 but carries a substantial debt of Rs 135 crore from IREDA, which has been weighing on the company's profitability. This divestment represents 10.53% of the company's net worth and is intended to deleverage the balance sheet. The transaction is expected to close by November 4, 2026, with proceeds primarily used for debt repayment.
Confidence: HIGH
What changedTruAlt is transitioning from holding a non-productive, debt-heavy asset to a leaner balance sheet by divesting its Karnataka-based Unit 5 via a slump sale.
Why it mattersThe move is financially strategic as it eliminates a non-core asset that was generating zero revenue while incurring significant interest expenses, thereby improving overall net margins and liquidity.
Sale Consideration: Rs 171 croreAssociated Debt to be Repaid: Rs 135 croreNet Worth Contribution: 10.53%FY26 Revenue Contribution: 0%Expected Completion Date: 04.11.2026
📅 Short termThe announcement is likely to be viewed positively by the market as it addresses debt concerns and improves the company's financial health.
📈 Long termStructurally positive as it allows management to focus capital and operational efforts on high-growth core segments like Ethanol and Sustainable Aviation Fuel (SAF).
⚠ Risk flags
- Execution risk pending definitive agreements
- Subject to customary closing adjustments and regulatory approvals
Key Highlights
Sale of Unit 5 (Badami Undertaking) for an aggregate consideration of Rs 171 crore
Unit 5 contributed 0% to the company's total turnover during FY26
Divestment removes an outstanding term loan of approximately Rs 135 crore from IREDA
The unit's net assets of Rs 159.32 crore represent 10.53% of the company's total net worth
Transaction is expected to be completed by November 4, 2026
👀 What to Watch
Investors should monitor the execution of the definitive agreement and verify the subsequent reduction in finance costs in the upcoming quarterly financial statements.
12x PAT Growth: TruAlt Bioenergy Q1 FY27 Total Income Doubles to ‡641 Cr on Dual-Feed Strategy
TruAlt Bioenergy reported a stellar Q1 FY27, with total income rising 96.37% YoY to ‡641.41 Cr and PAT surging over 12x to ‡59.27 Cr. The performance was driven by the successful transition to a dual-feed ethanol platform, which now accounts for 65% of the 2,000 KLPD total capacity. Grain-based operations proved 6% more profitable than sugar-based ones, enabling year-round production. While ethanol remains the core driver, the company is advancing its CBG and SAF projects, supported by a ‡150 Cr government grant.
Confidence: HIGH
What changedThe company has successfully transitioned from a seasonal mono-feed (sugar) producer to a year-round dual-feed (sugar and grain) ethanol platform.
Why it mattersThis shift de-risks the business from sugarcane seasonality, improves feedstock security, and captures higher margins from grain-based ethanol, significantly boosting the bottom line.
Q1 FY27 Total Income: ‡641.41 CrQ1 FY27 PAT: ‡59.27 CrQ1 Revenue vs FY26 Annual Revenue: 45.05%Installed Ethanol Capacity: 2,000 KLPDCapacity Utilization: 60.57%SAF Project Grant: ‡150 Cr
📅 Short termThe stock is likely to react positively to the massive earnings beat and the successful proof-of-concept for its dual-feed strategy.
📈 Long termThe company is positioning itself as a diversified bioenergy player with entries into CBG, SAF, and retail, which could lead to structural re-rating as these segments scale.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Raw material price volatility for grains (maize/rice) could impact COGS by 15-20%
- Geopolitical tensions causing a slowdown in retail fuel outlet expansion
- Government-controlled ethanol procurement prices
Key Highlights
Total income nearly doubled YoY to ‡641.41 Cr, representing ~45% of the entire FY26 revenue in just one quarter.
PAT grew by 1,154% YoY to ‡59.27 Cr, compared to ‡4.73 Cr in Q1 FY26.
Installed ethanol capacity increased 43% YoY to 2,000 KLPD, with 1,300 KLPD now dual-feed capable.
Grain-based ethanol production delivered approximately 6% higher profitability than traditional sugar-based production.
Sustainable Aviation Fuel (SAF) project received a ‡150 crore grant under the PM JI-VAN Yojana.
👀 What to Watch
Investors should monitor the ramp-up of capacity utilization from the current 60.57% and the execution progress of the 17 planned CBG plants and the SAF facility in Andhra Pradesh.
TruAlt Bioenergy Targets 100 Mn Litre SAF Plant; Secures ₹150 Cr Govt Grant
TruAlt Bioenergy is aggressively diversifying into high-margin segments, specifically Sustainable Aviation Fuel (SAF) and Compressed BioGas (CBG). The company has secured a ₹150 crore grant under the PM JI-VAN Yojana for its proposed 100 million liters per annum SAF facility in Andhra Pradesh, which has a 24-30 month commissioning timeline. While the core ethanol business (2,000 KLPD capacity) faced temporary allocation hurdles in ESY 2025-26, the company is scaling its retail footprint with 7 operational outlets and 4 more under construction. Strategic JVs with Sumitomo and GAIL are driving the CBG vertical, with 10+ plants currently in the pipeline or under construction.
Confidence: HIGH
What changedThe company has formalized its roadmap for the SAF segment with a secured government grant and provided a clear execution status for its CBG and retail expansion projects.
Why it mattersThis represents a strategic shift from being a pure-play ethanol producer to an integrated bioenergy platform, potentially reducing dependence on government-controlled ethanol pricing and entering higher-margin aviation and retail markets.
SAF Plant Capacity: 100 million litres/annumGovt Grant (PM JI-VAN): ₹150 crGrant vs TTM Revenue: ~10.5%Operational Retail Outlets: 7 unitsEthanol Capacity: 2,000 KLPD
📅 Short termThe market is likely to view the ₹150 cr grant and the clear SAF project timeline as a positive catalyst for the stock's valuation.
📈 Long termThe successful commissioning of the SAF and CBG plants could structurally re-rate the company by diversifying revenue streams and improving overall margins over the next 2-3 years.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for the 24-30 month SAF project timeline
- Raw material price volatility for multi-feed ethanol plants
- Geopolitical impacts on crude oil prices affecting retail fuel margins
Key Highlights
₹150 crore grant sanctioned under PM JI-VAN Yojana for the Sustainable Aviation Fuel (SAF) project
100 million liters per annum capacity planned for the SAF facility at Srikakulam, Andhra Pradesh
24-30 months estimated timeline for commissioning the SAF plant, currently moving towards the FEED stage
7 retail fuel outlets currently operational with 4 more under construction as part of a 100-outlet Phase 1 plan
2,000 KLPD total installed ethanol capacity, with 1,300 KLPD recently converted to dual-feed capability
👀 What to Watch
Monitor the execution timeline of the SAF project, specifically the completion of Front-End Engineering Design (FEED) and financial closure. Investors should also track the commissioning of the 4 CBG plants under the Sumitomo JV expected in FY27.
1155% PAT Surge: TruAlt Bioenergy Reports ₹59.27 Cr Profit in Q1 FY27
TruAlt Bioenergy delivered a robust Q1 FY27 performance with consolidated revenue jumping 106% YoY to ₹626.88 crore. Net profit (PAT) saw a massive surge to ₹59.27 crore from just ₹4.72 crore in the same period last year, reflecting the impact of expanded capacities. While YoY growth is exceptional, profit before tax saw a sequential decline from ₹94.24 crore in the March 2026 quarter to ₹78.44 crore. The company is currently finalizing the componentization of assets for its Unit 4, which was capitalized in February 2026.
Confidence: HIGH
What changedThe company has significantly scaled its operations compared to the previous year, benefiting from the capitalization of Unit 4 and dual-feed conversions.
Why it mattersThe sharp YoY growth validates the company's expansion strategy in the ethanol and bioenergy space, though high finance costs and sequential profit dips warrant observation.
Revenue (Q1 FY27): ₹626.88 crPAT (Q1 FY27): ₹59.27 crYoY Revenue Growth: 106.3%Finance Costs: ₹44.03 crEPS: ₹6.67
📅 Short termThe stock is likely to react positively to the massive YoY profit jump, although the sequential decline in PBT may temper the rally.
📈 Long termThe company is well-positioned to benefit from India's ethanol blending mandates and its entry into the Sustainable Aviation Fuel (SAF) market by FY28.
⚠ Risk flags
- High finance costs relative to revenue
- Pending fixed asset register updates for Unit 4
- Sequential decline in Profit Before Tax
Key Highlights
Consolidated Revenue from operations grew 106.3% YoY to ₹626.88 crore
Net Profit (PAT) surged 1155% YoY to ₹59.27 crore from ₹4.72 crore
Earnings Per Share (EPS) increased to ₹6.67 from ₹0.67 in the year-ago quarter
Finance costs remained high at ₹44.03 crore, accounting for 7% of total income
Unit 4 asset componentization is in progress following its February 2026 capitalization
👀 What to Watch
Investors should monitor the stabilization of margins as the company scales its multi-feed ethanol operations and the progress of the 17 planned CBG plants.
₹626.88 Cr Revenue in Q1 FY27; TruAlt Bioenergy Reports 106% YoY Revenue Growth
TruAlt Bioenergy reported a robust Q1 FY27 with consolidated revenue of ₹626.88 cr, marking a 106.3% increase from ₹303.89 cr in the same quarter last year. Net profit surged to ₹59.27 cr from ₹4.73 cr YoY, although it declined sequentially from ₹68.84 cr in March 2026. The results reflect the first full quarter of operations following the February 2026 capitalization of Unit 4's dual-feed conversion. While YoY growth is exceptional, the sequential dip in PAT and EPS (₹6.67 vs ₹7.93) suggests some margin pressure or higher operational costs.
Confidence: HIGH
What changedThe company has transitioned to a significantly higher revenue scale following the conversion of its plants to multi-feed (grain and sugarcane) capabilities.
Why it mattersThe shift to multi-feed capability reduces seasonal dependency on sugarcane, allowing for higher capacity utilization (projected 114% to 136% increase) and more consistent revenue streams.
Revenue (Q1 FY27): ₹626.88 crYoY Revenue Growth: 106.3%Net Profit (Q1 FY27): ₹59.27 crEPS (Q1 FY27): ₹6.67Finance Costs: ₹44.03 cr
📅 Short termThe market is likely to react positively to the massive YoY revenue and profit growth, though the sequential decline in PAT may lead to some consolidation.
📈 Long termThe company is well-positioned to benefit from India's ethanol blending targets and its expansion into Sustainable Aviation Fuel (SAF) by FY28.
⚠ Risk flags
- Raw material price volatility for maize and rice
- Government-controlled ethanol procurement prices
- Pending fixed asset register updates for Unit 4
Key Highlights
Consolidated Revenue from Operations grew 106.3% YoY to ₹626.88 cr.
Net Profit (PAT) stood at ₹59.27 cr, a significant jump from ₹4.73 cr in June 2025.
Cost of Materials Consumed was ₹333.52 cr, representing 53% of total revenue.
Finance costs remained high at ₹44.03 cr, compared to ₹37.79 cr in the year-ago quarter.
Auditors highlighted that the componentization of Unit 4 assets (capitalized Feb 2026) is still in progress.
👀 What to Watch
Watch for the stabilization of operating margins as the 1,300 KLPD dual-feed capacity ramps up and monitor the progress of the 17 planned CBG plants.
Rs 2,500 Cr Related Party Transaction Approved with Nirani Sugars for FY 2026-27
TruAlt Bioenergy shareholders have approved a material related party transaction (RPT) with Nirani Sugars Limited for the financial year 2026-27. The resolution allows for transactions up to an aggregate value of Rs 2,500 crore for the purchase and sale of goods and materials. The proposal was passed with an overwhelming 99.98% of the votes cast in favor. Given the company's reported revenue of Rs 595.52 crore in the March 2026 quarter, this transaction limit represents a very significant portion of the company's annual operating scale.
Confidence: HIGH
What changedShareholders have formally authorized the company to conduct high-value business transactions with a promoter-linked entity, Nirani Sugars, for the current fiscal year.
Why it mattersThe Rs 2,500 crore limit is substantial relative to TruAlt's revenue, indicating a high level of operational integration with the promoter group for feedstock or product off-take.
Transaction Limit: Rs 2,500 crVotes in Favor: 99.98%Transaction vs 3-Quarter Revenue: ~175%Record Date: 05-06-2026
📅 Short termThe approval is procedural and expected; no significant short-term price movement is anticipated solely based on this result.
📈 Long termThe heavy reliance on related parties for nearly double the current annualized revenue highlights a concentrated supply chain risk that investors should weigh against the benefits of integrated operations.
⚠ Risk flags
- High related-party concentration
- Transaction value exceeds annual revenue
Key Highlights
Shareholders approved a transaction limit of Rs 2,500 crore with Nirani Sugars Limited for FY 2026-27
The resolution passed with 99.9776% of votes in favor, totaling 6,250,561 votes
Public institutional participation stood at 77.03%, with 100% of those votes supporting the resolution
The transaction covers the purchase/sale of goods and materials at arm's length in the ordinary course of business
The record date for the postal ballot was June 5, 2026, with 64,689 total shareholders on record
👀 What to Watch
Investors should monitor quarterly financial statements to track the actual volume of transactions with Nirani Sugars and verify if margins remain consistent with arm's length pricing.
TruAlt Bioenergy FY26 Standalone PAT Drops 43% to ₹80.26 Cr; Revenue at ₹1,704.65 Cr
TruAlt Bioenergy reported a decline in its standalone performance for FY26, with revenue from operations falling 9.3% YoY to ₹1,704.65 crore. Profit After Tax (PAT) saw a sharper decline of 42.9%, dropping from ₹140.62 crore in FY25 to ₹80.26 crore in FY26. Despite the lower annual profit, the company successfully completed its ₹750 crore IPO in September 2025 and has transitioned three units to dual-feed capability to reduce seasonal dependence on sugarcane. A significant legal win allows the company a 90-day extension to supply ethanol worth approximately ₹1,075 crore to OMCs, which is expected to boost FY27 performance.
Key Highlights
Standalone Revenue from Operations decreased to ₹1,70,465.34 lakhs in FY26 from ₹1,88,011.66 lakhs in FY25.
Net Profit (PAT) for FY26 stood at ₹8,026.20 lakhs, a significant drop from ₹14,061.89 lakhs in the previous year.
Successfully raised ₹75,000 lakhs through an IPO in September 2025, with ₹72,021 lakhs already utilized as of March 31, 2026.
Secured a 90-day extension from the Karnataka High Court to fulfill an ethanol supply shortfall of 1,56,292 kilolitres valued at ~₹1,075 crore.
Upgraded Units 1, 2, and 4 to dual-feed capability (maize/rice) between Nov 2025 and Feb 2026 to ensure year-round operations.
👀 What to Watch
Investors should monitor the impact of the new dual-feed capabilities on FY27 margins and the company's ability to fulfill the ₹1,075 crore ethanol supply order within the court-mandated extension.
TruAlt Bioenergy Secures ₹150 Crore Govt Grant for 10 Crore Litre SAF Project
TruAlt Bioenergy has received approval for ₹150 crore in financial assistance under the PM JI-VAN Yojana for its commercial-scale Sustainable Aviation Fuel (SAF) project. The grant, approved by the Centre for High Technology, is expected to cover 7–10% of the project's capital expenditure, significantly enhancing project viability. The proposed facility will have a production capacity of 10 crore litres per annum, positioning the company to meet India's upcoming SAF blending mandates starting in 2027. This development reinforces TruAlt's leadership in the biofuels sector beyond its current 2,000 KLPD ethanol capacity.
Key Highlights
Approved for ₹150 crore financial assistance under the PM JI-VAN Yojana for Sustainable Aviation Fuel.
The grant will incentivize approximately 7–10% of the total project capital expenditure.
Planned SAF production capacity of 10 crore litres per annum to support India's 1% blending target by 2027.
The project aligns with CORSIA global aviation decarbonization standards and India's 5% blending target by 2030.
TruAlt currently maintains a dominant market position as India's largest ethanol producer with 2,000 KLPD capacity.
👀 What to Watch
Investors should view this as a significant de-risking event for the company's entry into the high-margin SAF market. Monitor the execution of the Memorandum of Agreement and the construction timeline for the 10 crore litre facility.
TruAlt Bioenergy Secures ₹150 Crore Govt Assistance for Sustainable Aviation Fuel Project
TruAlt Bioenergy has received approval for ₹150 crore in financial assistance under the PM JI-VAN Yojana for its Sustainable Aviation Fuel (SAF) project in Bagalkot, Karnataka. This grant is expected to cover approximately 7-10% of the total capital expenditure for the facility, which has a planned capacity of 10 crore litres per annum. The project aligns with India's mandatory SAF blending targets of 1% by 2027 and 5% by 2030. As India's largest ethanol producer with 2,000 KLPD capacity, this move diversifies TruAlt's portfolio into high-growth advanced biofuels.
Key Highlights
Approved ₹150 crore financial assistance from the Centre for High Technology under PM JI-VAN Yojana.
Proposed SAF facility in Bagalkot, Karnataka, with a production capacity of 10 crore litres per annum.
Government assistance to incentivize approximately 7-10% of the project's total capital expenditure.
Project supports India's SAF blending targets of 1% by 2027, 2% by 2028, and 5% by 2030.
TruAlt currently maintains a leading position as India's largest ethanol producer with 2,000 KLPD capacity.
👀 What to Watch
Investors should view this as a significant de-risking of TruAlt's expansion into the high-margin SAF market due to government backing. Monitor the execution timeline of the Bagalkot facility and the formal execution of the Memorandum of Agreement for fund disbursement.
TruAlt Bioenergy Seeks Approval for ₹2,500 Cr Related Party Transaction with Nirani Sugars
TruAlt Bioenergy Limited has issued a postal ballot notice seeking shareholder approval for material related party transactions with Nirani Sugars Limited. The company is proposing an aggregate transaction limit of up to ₹2,500 Crores for the Financial Year 2026-27. These transactions involve the purchase and sale of goods and materials in the ordinary course of business. The e-voting period is scheduled from June 10, 2026, to July 9, 2026, with results expected by July 11, 2026.
Key Highlights
Proposed Material Related Party Transaction (RPT) with Nirani Sugars Limited for FY 2026-27.
Aggregate transaction value capped at ₹2,500 Crores for the purchase/sale of goods and materials.
Approval sought via remote e-voting in compliance with SEBI LODR and Companies Act provisions.
E-voting period starts on June 10, 2026, and concludes on July 9, 2026.
Cut-off date for determining shareholder voting eligibility is June 5, 2026.
👀 What to Watch
Investors should review the explanatory statement to ensure the ₹2,500 Crore transaction is conducted at arm's length and monitor the voting results to gauge institutional sentiment regarding this large-scale related party engagement.
TruAlt Bioenergy FY26: Ethanol Capacity Reaches 60Cr Litres; CBG Expansion to 162 TPD
TruAlt Bioenergy reported a transformative FY26, completing the commissioning of five ethanol plants with a total capacity of 60 crore litres, though current utilization is restricted to 35% due to OMC allocation challenges. The company is scaling its Compressed Biogas (CBG) business through JVs with Sumitomo and GAIL, aiming to reach 162 TPD capacity by FY27 from the current 10 TPD. A new 10 crore litre per annum Sustainable Aviation Fuel (SAF) plant is also in development in Andhra Pradesh to utilize surplus ethanol. While ethanol sales face regulatory headwinds, the CBG segment remains highly profitable with EBITDA margins exceeding 55%.
Key Highlights
Ethanol production capacity reached 60 crore litres, but current sales run rate is only 2.2 crore litres per month due to allocation issues.
CBG vertical achieved 85%+ capacity utilization with EBITDA margins exceeding 55% on total revenue.
Formed JVs with Sumitomo and GAIL (49% each) to expand CBG capacity from 10 TPD to 162 TPD by FY27.
Signed MOU for a 10 crore litre per annum Sustainable Aviation Fuel (SAF) plant in Andhra Pradesh using Honeywell technology.
Seeking legal implementation for an additional 15 crore litre ethanol allocation to reach peak production capacity.
👀 What to Watch
Investors should monitor the resolution of the ethanol allocation dispute with OMCs and the execution timeline of the SAF and CBG projects. The high-margin CBG expansion and entry into SAF provide significant long-term growth potential despite current ethanol utilization headwinds.
TruAlt Bioenergy Q4 FY26: Legal Win for 15 Crore Litre Ethanol Supply Worth ₹1,062 Crore
TruAlt Bioenergy reported its Q4 FY26 results, highlighting a strategic transition to a 1,300 KLPD dual-feed ethanol infrastructure within its 2,000 KLPD total capacity. Despite industry-wide allocation cuts, the company secured a legal victory to supply 15 crore litres of ethanol, representing a revenue potential of ₹1,062 crore. The company is also diversifying into Sustainable Aviation Fuel (SAF) with a proposed 100 million litres/annum plant and expanding its CBG segment through JVs with GAIL and Sumitomo.
Key Highlights
Secured Karnataka High Court order for 15 crore litres of ethanol supply with ₹1,062 crore revenue potential
Integrated 1,300 KLPD dual-feed infrastructure into total 2,000 KLPD ethanol capacity for year-round operations
Proposed 100 million litres/annum Sustainable Aviation Fuel (SAF) plant in Andhra Pradesh with ₹150 crore VGF potential
Expanding CBG footprint with 4 plants under construction and 6 more in the pipeline via JVs with GAIL and Sumitomo
Retail network includes 7 operational outlets with 76 prospective locations shortlisted for future expansion
👀 What to Watch
Investors should monitor the execution timeline of the 15 crore litre ethanol supply order as it is critical for revenue recovery following recent industry disruptions. The progress of the SAF project and CBG joint ventures will be the primary long-term growth drivers to watch.
TruAlt Bioenergy Approves FY26 Audited Results with Unmodified Auditor Opinion
TruAlt Bioenergy's Board of Directors has approved the audited standalone and consolidated financial results for the quarter and fiscal year ended March 31, 2026. The statutory auditors, M/s N. M. Raiji & Co., issued an unmodified opinion, signaling that the financial statements present a true and fair view of the company's finances. Additionally, the company has strengthened its oversight by appointing M/s ZADN and Associates LLP as Internal Auditors and M/s R. Nanabhoy & Co. as Cost Auditors for FY 2026-27. These routine but essential appointments ensure continued regulatory compliance and internal control efficiency.
Key Highlights
Approved audited standalone and consolidated financial results for the fiscal year ended March 31, 2026.
Statutory auditors issued a clean report with an unmodified opinion on the FY26 financial results.
Appointed M/s ZADN and Associates LLP as Internal Auditors for the financial year 2026-27.
Appointed M/s R. Nanabhoy & Co. as Cost Auditors for the financial year 2026-27.
The board meeting concluded within approximately 90 minutes, indicating efficient approval of agenda items.
👀 What to Watch
Investors should review the detailed financial tables in Annexure-I to assess revenue and profit growth trends. The unmodified auditor opinion is a positive indicator of the company's financial reporting integrity.
India Ratings Assigns 'IND A-' Rating to TruAlt Bioenergy's ₹1,766 Crore Bank Facilities
India Ratings has assigned a first-time 'IND A-' rating with a stable outlook to TruAlt Bioenergy's ₹1,766 crore bank facilities, citing its position as India's largest ethanol producer with a 2,000 klpd capacity. The company has a strong order book to supply 505 million liters in ESY26, which is expected to drive significant revenue growth in FY27. While the company is undergoing a large ₹10.5 billion capex for Compressed Biogas (CBG) plants, its recent ₹7.5 billion IPO fresh issue has strengthened the balance sheet. Analysts expect net leverage to improve to below 3.5x by FY27 as new capacities and grain-based feedstock integration stabilize.
Key Highlights
Assigned 'IND A-/Stable' and 'IND A2+' ratings for ₹17,660 million bank loan facilities.
India's largest cane-based distillery with 2,000 klpd capacity and a 505 mnL ethanol order book for ESY26.
9MFY26 consolidated revenue grew 13% YoY to ₹11.2 billion with EBITDA of ₹1.9 billion.
Planned ₹10.5 billion capex for 21 CBG plants in JVs with GAIL India and Sumitomo Corporation.
Net leverage expected to improve from 4.5x in FY25 to below 3.5x by FY27 following IPO fund utilization.
👀 What to Watch
Investors should take this investment-grade rating as a positive sign of the company's creditworthiness and scale post-listing. Monitor the timely execution of the CBG projects and any regulatory changes to ethanol blending prices which could impact margins.
GAIL Infuses ₹130 Million in TruAlt Bioenergy Subsidiary Leafiniti for 49% Stake
GAIL (India) Limited has invested ₹130 million in TruAlt Bioenergy's subsidiary, Leafiniti Bioenergy, to acquire a 49% equity stake. This strategic partnership will fund the first phase of a joint venture to establish six greenfield Compressed Biogas (CBG) plants with a combined annual capacity of 23,976 tonnes. The collaboration combines TruAlt's bioenergy expertise with GAIL's extensive gas infrastructure and market reach. Beyond energy, the plants are expected to produce over 5.6 lakh tonnes of organic manure annually, enhancing the company's circular economy revenue streams.
Key Highlights
GAIL acquires 49% stake in subsidiary Leafiniti Bioenergy for ₹130 million investment.
Phase 1 includes 6 greenfield plants with 12 tonnes per day capacity each, totaling 23,976 tonnes of CBG annually.
Projects expected to generate 97,902 tonnes of FOM and 4,70,862 tonnes of Liquid FOM annually.
Joint venture targets expansion across Karnataka, Maharashtra, and Odisha to displace 19,800 tonnes of fossil fuels per year.
TruAlt Bioenergy retains a 51% controlling stake in the subsidiary post-transaction.
👀 What to Watch
Investors should view this partnership with a PSU giant like GAIL as a significant validation of TruAlt's scalability and strategic positioning in the green energy sector. Monitor the execution and commissioning timelines of the first six plants as they will be critical for revenue ramp-up.
TruAlt Bioenergy Q3 Revenue Surges 70% YoY; All 5 Ethanol Plants Now Fully Operational
TruAlt Bioenergy reported a robust 70% YoY growth in Q3 total income to ₹730.86 crore, driven by the commissioning of its fifth ethanol unit. While 9M PAT grew marginally to ₹35.92 crore, the company has established a monthly revenue run rate of ₹350-400 crore in the ethanol segment. The CBG business remains highly profitable with a 63% EBITDA margin, and the company is scaling up with 24 new units via JVs with GAIL and Sumitomo. Management expects stronger momentum in Q4 as capacity utilization stabilizes across all units.
Key Highlights
Total income for Q3 FY26 rose 70% YoY to ₹730.86 crore; 9M income reached ₹1,187 crore.
Ethanol segment achieved a monthly revenue run rate of ₹350-400 crore with all 5 plants now operational.
CBG business reported robust 9M EBITDA margins of 63% and PAT margins of 43%.
Planned expansion of 24 Greenfield CBG units through JVs with Sumitomo and GAIL over 2-3 years.
Advancing a 100 million liters per annum Sustainable Aviation Fuel (SAF) facility in Andhra Pradesh.
👀 What to Watch
Investors should monitor the ramp-up in ethanol production and the execution of the CBG JVs, which offer high-margin growth. The stock remains a key play on India's biofuel and energy transition mandates.
TruAlt Bioenergy Wins Court Order for ₹1,075 Cr Ethanol Supply Extension
TruAlt Bioenergy has received a favorable ruling from the Hon’ble High Court of Karnataka regarding a shortfall in ethanol supply to Oil Marketing Companies (OMCs). The court has directed OMCs to consider the company's request for a 90-day extension to supply 1,56,292 KL of ethanol originally allocated for Q3 and Q4 of ESY 2024-25. This quantity carries an estimated value of approximately ₹1,075 crore, and the extension would allow the company to fulfill its contractual obligations and recognize the associated revenue. The OMCs are required to decide on the company's representation within 10 days of the order receipt.
Key Highlights
High Court of Karnataka allowed the writ petition for a 90-day extension to supply ethanol shortfall.
The dispute involves 1,56,292 KL of ethanol allocated for the Third and Fourth quarters of ESY 2024-25.
The estimated value of the contracted quantity under consideration is approximately ₹1,075 crore.
OMCs including BPCL, HPCL, and IOCL are directed to consider the representation within 10 days.
Successful fulfillment of these quantities is expected to have a positive impact on the company's financial performance.
👀 What to Watch
Investors should view this as a significant positive development that potentially secures ₹1,075 crore in revenue; monitor for the OMCs' formal approval of the extension within the next two weeks.
TruAlt Bioenergy Q3 FY26 Revenue Jumps 70% to ₹731 Cr; EBITDA Up 7.5%
TruAlt Bioenergy reported a robust 69.75% YoY growth in total income to ₹730.86 crore for Q3 FY26, driven by the commissioning of grain-based integration and expanded plant operations. While EBITDA grew 7.54% to ₹134 crore, PAT saw a slight decline of 7.98% to ₹69.19 crore due to transitional operating factors. The company has achieved full operational status for all five ethanol plants, positioning it for near year-round production. Strategic expansions are underway in Compressed Biogas (CBG) with 24 planned units and a 100 million litre Sustainable Aviation Fuel (SAF) project.
Key Highlights
Total income increased 69.75% YoY to ₹730.86 crore in Q3 FY26.
EBITDA rose to ₹134.00 crore, though consolidated EBITDA margins compressed to 18.79% from 30.02% YoY.
Ethanol production capacity stabilized at 5.5 to 6 crore litres per month with all 5 units now operational.
CBG segment recorded 63% EBITDA margins for 9M FY26 with plans for 24 greenfield units via JVs with GAIL and Sumitomo.
Progressing on a 100 million litres per annum SAF facility in Andhra Pradesh with Honeywell UOP technology.
👀 What to Watch
Investors should focus on the company's ability to restore margins as it moves past the 'transitional' phase into full-scale operations. The aggressive diversification into CBG and SAF offers significant long-term growth potential, but execution of the JV projects remains the primary monitorable.
